Publications

Antimicrobial Activity of Daptomycin and Selected Comparators Tested against Staphylococcus aureus Causing Bloodstream Infections (BSI) in Dialysis Patients, Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

In Vitro Activity of Telavancin Against Gram-positive Pathogens, Including Resistant Subsets: Results from a Global Surveillance Program (2007), Lead author: Fritsche TR, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

In Vitro Activity of Omiganan Pentahydrochloride (OMI) Against >1,600 Clinical Trial Isolates, Lead author: Fritsche TR, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Linezolid (LZD) Experience and Accurate Determination of Resistance (LEADER) Program 2006: Emerging Oxazolidinone and Inducible Clindamycin (CC) Resistances (R), Lead author: Jones RN, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Susceptibility Profiles of Bacterial Isolates from Bloodstream Infections of Transplant Recipient Patients, Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Occurrences of ESBL and Other ß-lactamases (BL) Among Enterobacteriaceae (ENT) Isolated in USA Medical Centers: 10-Year Report from the SENTRY Program, Lead author: Jones RN, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Susceptibility of Gram-Positive (GP) Organisms Isolated from North American (NA) Hospitals: Results from the Daptomycin (DAP) Surveillance Program, 2004 – 2006, Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Activity of Daptomycin Tested against Gram-positive Organisms Collected from Hospitalized Patients with Cancer Hospitalized in the United States (USA) Hospitals, Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Assessment of Tigecycline (TGC) and Other Broad-Spectrum Agents Activities Tested Against Enterobacteriaceae (ENT) from the Asia-Pacific Region (2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Activity of Tigecycline and Comparator Agents Tested Against Gram-Positive (GP) Organisms Collected in the Asia-Pacific Region in 2006, Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Tigecycline: An Active Antimicrobial Agent against Multidrug-Resistant Acinetobacter spp. Isolated in Latin America, Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Evaluation of Cefditoren (CDN) and Comparator Oral &#223-lactam Agents Tested Against Recent Community-Acquired Streptococcus pneumoniae (USA; 2004-2006), Lead author: Fritsche TR, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Potency of Omiganan Pentahydrochloride (OMI): Evidence for Retained or Enhanced Activity When Formulated in a Gel Matrix, Lead author: Fritsche TR, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Activity of Cefditoren (CDN) Tested Against Haemophilus influenzae (HI) and Moraxella catarrhalis (MCAT) Causing Community-Acquired Respiratory Tract Infections (USA; 2004-2006), Lead author: Fritsche TR, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Quinolone Resistant Escherichia coli at a Cancer Center, Lead author: Rolston KV, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Evaluation of Susceptibility Patterns of Klebsiella spp. Isolated in Latin America. Results of the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Susceptibility of Pseudomonas aeruginosa (PSA) Causing Bloodstream Infections (BSI) in Brazilian Medical Centers: Results of the SENTRY Antimicrobial Surveillance Program (2001-2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Metallo-&#223-Lactamases Genes, bla_IMP-15 and bla_IMP-18 in a Class 1 Integrons form Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico, Lead author: Garza-Ramos U, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Spectrum and Potency of Tigecycline Tested Against Non-Fermentative Gram-negative Bacilli (NFGN) Collected in Across the Asia-Pacific Region (2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA

Antimicrobial Activity of Telavancin Against Contemporary Enterococci and Streptococci: Initial Results from a Global Surveillance Program (2007), Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

GES-Producing Pseudomonas aeruginosa (PSA): Prevalence, Genetic Relatedness and Analysis of the bla_GES Genetic Context, Lead author: Picao, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Detection of Methyltransferases (MT) Conferring High-Level Resistance (R) to Aminoglycosides (AG) in Enterobacteriaceae (ENT) from Europe, North America and Latin America, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Enterobacter spp. in the Asia-Pacific (APAC) Region: A SENTRY Antimicrobial Surveillance Program Report (2006), Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Dissemination of IMP-Type Metallo-β-Lactamases among Pseudomonas aeruginosa and Emergence of VIM-2 in Klebsiella oxytoca in Mexico: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Initial Occurrences of Linezolid (LZD) Resistance (R) from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program (Europe, Latin, America, Asia Pacific), Lead author: Ross JE, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

To Split, or Not to Split a MIC Distribution, That is the Question: Setting Susceptibility Breakpoints, Lead author: Bhavnani SM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Detection of Antimicrobial Susceptibility Testing (AST) Errors by Automated Systems: College of American Pathologists (CAP) Microbiology Surveys Results for 2003-2006, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Critical Evaluation of Linezolid Susceptibility (S) Testing Using Two Automated Systems (Vitek, Vitek 2), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Intermethod Comparability Analyses of Tigecycline Antimicrobial Susceptibility Tests (AST) Using over 5,000 Pathogens Isolated in Asia-Pacific Countries, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Proposed Disk Diffusion (DD) Quality Control (QC) Ranges for Ulifloxacin (ULI) and Intermethod Comparison Using CLSI Broth Microdilution and DD, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Selection of a Surrogate Carbapenem (CARB) Testing Agent for Initial Susceptibility (S) Testing of Doripenem (DOR), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Re-Evaluations of H. influenzae (HI) Susceptibility (S) Tests for Penicillins ± β-Lactamase Inhibitors against β-Lactamase-Negative Ampicillin-Resistant (BLNAR) Strains: a SENTRY Program Report, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Ulifloxacin Tested against a Worldwide Collection of Pathogens Producing Traveler’s Diarrhea, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of Omiganan Pentahydrochloride against Contemporary (2005-2006) Gram-Negative Pathogens Responsible for Local Catheter Site Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Omiganan against Contemporary (2005-2006) Gram-Positive Pathogens Responsible for Catheter Colonization and Catheter-Related Bloodstream Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Doripenem Activity Tested Against Gram-Negative Pathogens in the Asia-Pacific (APAC) Region: Report from the SENTRY Antimicrobial Surveillance Program, 2006, Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of PZ-601 (SMP-601) Tested against Selected Wildtype (WT) and Resistant (R) Collection of Targeted Species (U.S. and Europe), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Ceftobiprole (BPR) Tested against Gram-Positive and -Negative Pathogens in the Asia-Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Bell JM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of ME1036 and Ceftaroline Tested against Clinical Strains of Community-Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Tigecycline (TGC) Tested against Clinical Pathogens Collected in Korea, the Philippines, Singapore and Thailand (2006), Lead author: Bell JM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of Iclaprim Tested against Recent Staphylococcus aureus Clinical Isolates: Results from the International Study of Iclaprim Susceptility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Iclaprim and Comparison Agents Tested against Neisseria gonorrhoeae Including Growth Stimulating Effects, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of a Novel Dihydrofolate Reductase, Iclaprim, Tested against Clinical Strains of Enterobacteriaceae (ENT): Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Comparative Evaluation of Iclaprim Potency and Bactericidal Activity Tested against Enterococci: Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against &#223-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS)., Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Evaluation of the Novel Ceragenin, CSA-13 Activity and Potential Synergy (SYN) against Clinical Isolates of Pseudomonas aeruginosa (PA), Including Multi-Drug Resistant PA (MDR-PA), Lead author: Chin JN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Discovery of EP-014887: A Novel Oxime 3,6-Bicyclolide with High Potency against MRSA and a Favorable In Vivo Efficacy Profile, Lead author: Tang D, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL